MOESM1 of Production of a cellular product consisting of monocytes stimulated with SylatronÂŽ (Peginterferon alfa-2b) and ActimmuneÂŽ (Interferon gamma-1b) for human use

Green, Daniel; Nunes, Ana; Tosh, Kevin; David-Ocampo, Virginia; Fellowes, Vicki; Ren, Jiaqiang; Jin, Jianjian; Frodigh, Sue-Ellen; Pham, Chauha; Procter, Jolynn; Tran, Celina; Ekwede, Irene; Khuu, Hanh; Stroncek, David; Highfill, Steven; Zoon, Kathryn; Annunziata, Christina

doi:10.6084/m9.figshare.7849943.v1

12967_2019_1822_MOESM1_ESM.docx (139.07 kB)

MOESM1 of Production of a cellular product consisting of monocytes stimulated with SylatronÂŽ (Peginterferon alfa-2b) and ActimmuneÂŽ (Interferon gamma-1b) for human use

journal contribution

posted on 2019-03-14, 05:00 authored by Daniel Green, Ana Nunes, Kevin Tosh, Virginia David-Ocampo, Vicki Fellowes, Jiaqiang Ren, Jianjian Jin, Sue-Ellen Frodigh, Chauha Pham, Jolynn Procter, Celina Tran, Irene Ekwede, Hanh Khuu, David Stroncek, Steven Highfill, Kathryn Zoon, Christina Annunziata

Additional file 1. Additional tables.

Funding

National Cancer Institute (US)

History

Usage metrics

Keywords

Cell therapy Cellular immunotherapy Monocytes Interferons Innate immunity

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

MOESM1 of Production of a cellular product consisting of monocytes stimulated with SylatronÂŽ (Peginterferon alfa-2b) and ActimmuneÂŽ (Interferon gamma-1b) for human use

Funding

National Cancer Institute (US)

History

Usage metrics

Categories

Keywords

Licence

Exports